Form 4: Maravai LifeSciences Director Transfers Shares to Family Partnership

Gregory T. Lucier, a director at Maravai LifeSciences, gifted 20,645 shares of Class A Common Stock to a family partnership.

Summary

• Gregory T. Lucier, a director at Maravai LifeSciences Holdings, Inc., transferred 20,645 shares of Class A Common Stock to a family partnership on December 9, 2024.
• The shares were transferred as a gift, with no monetary value exchanged.
• Following the transaction, Mr. Lucier directly owns 55,123 shares and indirectly owns 20,645 shares through the family partnership.
• The family partnership includes a trust for the benefit of Mr. Lucier, and his spouse serves as the general partner, potentially having voting and dispositive power over the shares.
• Mr. Lucier disclaims beneficial ownership of the shares held by the partnership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction and has no significant positive or negative implications for the company's performance or outlook.

Industry Context

This is a routine transaction for a company director and does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Transactions of this nature are common among corporate insiders and are typically disclosed via SEC Form 4 filings.
• The transfer of shares to a family partnership is a common estate planning strategy.

Stakeholder Impact

• The transaction has no immediate impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Maravai LifeSciences, MRVI, Gregory T. Lucier, stock transfer, family partnership, beneficial ownership, director, SEC Form 4